What insurance policy changes affect code J30.0?

There are 3 tracked policy changes affecting code J30.0, including updates from Excellus BlueCross BlueShield, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code J30.0?

Payers that have issued tracked updates for code J30.0 include: Excellus BlueCross BlueShield, Aetna.

How do I get notified when code J30.0 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code J30.0. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code J30.0?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

J30.0 Insurance Policy Changes

ICD-10 J30.0 is officially defined as "Vasomotor rhinitis." code J30.0 is referenced in 3 tracked payer policy changes from Excellus BlueCross BlueShield and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code J30.0 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Excellus BlueCross BlueShield · Effective Jul 16, 2026Medium impact
Allergy Testing 2.01.10
Percutaneous, combined percutaneous and intracutaneous, intracutaneous, patch, photo patch, photo, inhalation bronchial challenge, ingestion challenge, and gammaglobulin IgE tests are medically appropriate in the diagnosis of the allergic patient, with allergen-specific IgE medically appropriate only under specified circumstances. Allergen-specific IgG when the criteria are not met, the leukocyte histamine release test, ophthalmic and direct nasal mucous membrane tests, peanut allergen-specific ELISA testing, and cytotoxicity, provocative, and Rebuck skin window tests are investigational, and allergy testing for treatment programs such as tolerance induction programs is investigational. The July 16, 2026 update was an annual review with the policy intent unchanged.
Aetna · Identified Aug 17, 2026Medium impact
Hair Analysis (CPB 0300, reviewed 2026-04-17)
Aetna considers chemical hair analysis experimental, investigational or unproven, except for diagnosis of suspected chronic arsenic poisoning, and considers hair analysis of brain-derived neurotrophic factor as a predictor of developing psychopathological symptoms in childhood experimental, investigational or unproven. Microscopic evaluation of hair structure (trichogram) may be medically necessary as part of the work-up of members with alopecia or abnormal-appearing or abnormally growing hair.
Aetna · Identified Aug 16, 2026Medium impact
Sinus Surgeries (CPB 0937, reviewed 2026-04-10)
Aetna's Clinical Policy Bulletin 0937 treats endoscopic sinus surgery as medically necessary for specific indications, including allergic fungal rhino-sinusitis with CT evidence, antro-choanal polyp, chronic rhino-sinusitis longer than 12 continuous weeks with or without nasal polyps that has failed maximal medical treatment and shows objective CT evidence, recurrent acute rhino-sinusitis meeting listed criteria, sinusitis complications, and mucocele, and as experimental, investigational, or unproven for all other indications. Revision surgery requires at least 12 weeks since the previous surgery, chronic rhino-sinusitis for at least 12 continuous weeks, failure of at least one 5 to 7 day course of antibiotics since the previous surgery, and persistent objective CT evidence of sinus disease. Balloon sinus ostial dilation is medically necessary for uncomplicated sinusitis without nasal polyposis when the Appendix criteria are met and is experimental for listed cases such as nasal polyposis grade 2 or greater, repeat balloon procedures, and Samter's triad, while sphenopalatine artery ligation with posterior nasal nerve ablation is experimental for vasomotor rhinitis.

Watch J30.0

Get one email when a payer policy names J30.0, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Allergy Testing 2.01.10

Hair Analysis (CPB 0300, reviewed 2026-04-17)

Sinus Surgeries (CPB 0937, reviewed 2026-04-10)

What insurance policy changes affect code J30.0?

Which payers have updated policy for code J30.0?

How do I get notified when code J30.0 policy changes?

Why do payers change policies for code J30.0?